Statement on the FDA’s benefit-risk framework for evaluating opioid analgesics - FDA Press Releases

FDA issues a new draft guidance on the application of the benefit-risk assessment framework for evaluating applications for opioids.

from FDA Press Releases RSS Feed http://bit.ly/2WVpnJF
via IFTTT